What does the research say about Limosilactobacillus abundance?

Limosilactobacillus abundance

There are 3 papers on Limosilactobacillus abundance in aging research: 1 observational study in people, 2 in animals. The newest story, Nov 13, 2026: “Gut microbes linked to major cardiovascular events”.

Biomarker

3 papers study it1 more mentions it1 finding

2 new papers in 30 daysSee all 4 papers on Limosilactobacillus abundance

“higher abundance of genera Scardovia (HR=1.17 [95% CI 1.08-1.26], p= 0.0001) and Limosilactobacillus (HR=1.16 [95%CI 1.09-1.23], p= 1E-06) was associated with increased MACE risk”

Gut microbiome and incidence of major adverse cardiovascular events in the general population: a prospective study in five European cohortsmedRxiv2026doi:10.64898/2026.11.10.26367787

Humans1
Animals2

Associations

Major adverse cardiovascular events

upin humans1HR 1.16

1 study

Limosilactobacillus abundance is associated with major adverse cardiovascular events in humans (HR 1.16, 95% CI 1.09–1.23).
“higher abundance of genera Scardovia (HR=1.17 [95% CI 1.08-1.26], p= 0.0001) and Limosilactobacillus (HR=1.16 [95%CI 1.09-1.23], p= 1E-06) was associated with increased MACE risk”
Humans
Gut microbes linked to major cardiovascular events
medRxivNov 12, 2026Preprint

More on Major adverse cardiovascular events

Latest

4 papers in 12 months

medRxivNov 13

Gut microbes linked to major cardiovascular events

Higher versus lower levels of Scardovia bacteria were linked to higher cardiovascular event risk, with a hazard ratio, a relative-risk measure, of 1.17.Higher versus lower levels of Scardovia bacteria were linked to higher cardiovascular event risk, with a hazard ratio, a relative-risk measure, of 1.17.

Preprint: meta-analysis · 30,228 peopleBiomarkers